Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that fat tissue in the skin is a new finding in Frontal fibrosing alopecia and may contribute to hair follicle and muscle degeneration.

The Fas/FasL pathway may play a role in alopecia areata.

FOL-005 peptide may help treat excessive hair growth safely.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

Fenoterol treatment causes increased hair growth due to higher metabolism in hair follicles, not hormones.

FLRG and follistatin have different roles in wound healing.

Fzd2 is important for skin and hair development through various signaling ways.

The fuzzy gene is crucial for controlling hair growth cycles.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Autologous growth factor concentrate therapy shows promise for treating early-stage hair loss safely and effectively.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Early combination therapy can effectively regrow hair in frontal fibrosing alopecia.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Isotretinoin and other medications showed promising results for treating a rare scalp condition linked to severe acne.

The commentary suggests that certain hair and skin care products may be linked to frontal fibrosing alopecia, but not sunscreens, and calls for more thorough research on the causes.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

FGF21 can help reduce skin inflammation caused by C. acnes.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Active oxygen scavengers can reverse the suppression of hair cell growth caused by androgens.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.